Diabetes Updates

‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 billion in direct healthcare costs each year. Researchers from the Baker Heart and Diabetes Institute, Melbourne say Australia’s cholesterol problem remains unsolved as cardiovascular disease

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Diabetes dynamos
Next 100 years since the discovery of insulin: the roadmap to our next big breakthrough